methylene blue has been researched along with Neurodegenerative Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Aksinenko, AY; Bachurin, SO; Boltneva, NP; Dubova, LG; Epishina, TA; Fisenko, VP; Goreva, TV; Grigoriev, VV; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Pushkareva, EA; Richardson, RJ; Rudakova, EV; Serkova, TP; Shevtsov, PN; Shevtsova, EF; Veselov, IM; Vinogradova, DV | 1 |
de Beer, F; Petzer, A; Petzer, JP | 1 |
Baek, S; Baik, JH; Choi, E; Jeong, K; Kim, B; Kim, D; Kim, S; Kim, YK; Lee, BH; Lee, JJ; Lee, KP; Lim, S; Park, J; Shin, S | 1 |
Aksinenko, AY; Aliev, G; Bachurin, SO; Boltneva, NP; Dubova, LG; Fisenko, VP; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Shevtsova, EF; Sokolov, VB; Vinogradova, DV | 1 |
Forster, M; Li, W; Liu, R; Simpkins, JW; Sumien, N; Yang, SH | 1 |
Agrawal, N; Aron, R; Finkbeiner, S; Glabe, C; Lau, A; Lotz, GP; Marsh, JL; Muchowski, PJ; Necula, M; Sontag, EM; Thompson, LM; Tran, A; Yang, G | 1 |
Barthel, H; Burchert, W; Dannenberg, C; Kämpfer, I; Kluge, R; Knapp, WH; Seese, A | 1 |
1 review(s) available for methylene blue and Neurodegenerative Diseases
Article | Year |
---|---|
Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.
Topics: Animals; Brain; Electron Transport; Humans; Methylene Blue; Mitochondria; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents | 2017 |
6 other study(ies) available for methylene blue and Neurodegenerative Diseases
Article | Year |
---|---|
Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease.
Topics: Alzheimer Disease; Calcium; Cholinesterase Inhibitors; Cholinesterases; Humans; Ligands; Methylene Blue; Neurodegenerative Diseases; Receptors, N-Methyl-D-Aspartate | 2022 |
Monoamine oxidase inhibition by selected dye compounds.
Topics: Acridine Orange; Anthraquinones; Azure Stains; Coloring Agents; Drug Design; Humans; Methylene Blue; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Oxazines; Structure-Activity Relationship | 2020 |
Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Injuries, Traumatic; Cell Line; Drug Carriers; Humans; Male; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nanostructures; Neurodegenerative Diseases; Neuroprotective Agents; Nootropic Agents; Permeability; Poloxamer | 2018 |
Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.
Topics: Acetylcholinesterase; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase; Carbolines; Carboxylesterase; Cholinesterase Inhibitors; Erythrocytes; Horses; Humans; Kinetics; Methylene Blue; Molecular Docking Simulation; Neurodegenerative Diseases; Swine | 2019 |
Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
Topics: Analysis of Variance; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Drosophila; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Huntingtin Protein; Huntington Disease; Kynurenic Acid; Methylene Blue; Mice; Mice, Inbred C57BL; Microscopy, Atomic Force; Mutation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Psychomotor Performance; Rats; Rotarod Performance Test; Transfection; Trinucleotide Repeat Expansion | 2012 |
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Disorders; Cobalt; Cysteine; Depression; Drug Stability; Female; Humans; Male; Methylene Blue; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Scalp; Sensitivity and Specificity; Sleep Apnea Syndromes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |